Identification and Characterization of Fenofibrate-Induced Liver Injury.
Jawad AhmadJoseph A OdinPaul H HayashiNaga ChalasaniRobert J FontanaHuiman BarnhartElizabeth T CirulliDavid E KleinerJay H HoofnaglePublished in: Digestive diseases and sciences (2017)
Liver injury after fenofibrate exposure occurs with variable latency, enzyme elevation, and histology. Although most cases are self-limited, severe injury and mortality can occur, particularly if drug withdrawal is delayed. Jaundice or abnormal laboratory tests during fenofibrate therapy should trigger prompt discontinuation.